Pulmonary Volume Changes During Synchonized Noninvasive Positive Pressure Ventilation

Recruiting Observational Study
Infant, Preterm Respiratory Distress Syndrome (Neonatal) Chronic Lung Disease of Newborn Respiratory Support Synchronized Noninvasive Positive Pressure Ventilation (SNIPPV) Lung Volume
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
Up to 4 Weeks
Sex
Any
Study type
Observational
Participants needed
27 (estimated)
Sponsor
University of Zurich · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Current evidence suggests that noninvasive positive pressure ventilation (NIPPV) is more effective than continuous positive airway pressure (CPAP) in preventing respiratory failure in preterm infants with respiratory distress syndrome (RDS), both as initial and post-extubation support. NIPPV may be delivered in synchronized (sNIPPV) or non-synchronized (nsNIPPV) modes, with sNIPPV offering clear b…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Written informed consent by one or both parents or legal guardians * Gestational age at birth \< 30 0/7 weeks * Infants on sNIPPV respiratory support * Below 4 weeks chronological age Exclusion Criteria: * Severe congenital malformation adversely affecting lung aeration or p…
Contacts

Christoph M Rüegger, MD

+41432539810

christoph.rueegger@usz.ch

CONTACT

Claudia Knöpfli

+41442555340

claudia.knoepfli@usz.ch

CONTACT